337 related articles for article (PubMed ID: 16487557)
21. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2008 Oct; 36(10):1983-91. PubMed ID: 18583509
[TBL] [Abstract][Full Text] [Related]
22. Effect of ethynylestradiol on biliary excretion of bile acids, phosphatidylcolines, and cholesterol in the bile fistula rat.
Kern F; Eriksson H; Curstedt T; Sjövall J
J Lipid Res; 1977 Sep; 18(5):623-34. PubMed ID: 903709
[TBL] [Abstract][Full Text] [Related]
23. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat.
Jacquemin E; Dumont M; Mallet A; Erlinger S
Eur J Clin Invest; 1993 Dec; 23(12):794-802. PubMed ID: 8143756
[TBL] [Abstract][Full Text] [Related]
24. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
25. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
26. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
[TBL] [Abstract][Full Text] [Related]
27. Regulation of bile acid synthesis. I. Effects of conjugated ursodeoxycholate and cholate on bile acid synthesis in chronic bile fistula rat.
Heuman DM; Hernandez CR; Hylemon PB; Kubaska WM; Hartman C; Vlahcevic ZR
Hepatology; 1988; 8(2):358-65. PubMed ID: 3356417
[TBL] [Abstract][Full Text] [Related]
28. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
[TBL] [Abstract][Full Text] [Related]
29. Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets.
Duerksen DR; Van Aerde JE; Gramlich L; Meddings JB; Chan G; Thomson AB; Clandinin MT
Gastroenterology; 1996 Oct; 111(4):1111-7. PubMed ID: 8831607
[TBL] [Abstract][Full Text] [Related]
30. Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.
Di Guida F; Pirozzi C; Magliocca S; Santoro A; Lama A; Russo R; Nieddu M; Burrai L; Boatto G; Mollica MP; Sodano F; Lazzarato L; Chegaev K; Meli R; Raso GM; Rimoli MG
Mol Pharm; 2018 Jan; 15(1):21-30. PubMed ID: 29140706
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of 17alpha-ethinylestradiol on the neutral and acidic pathways of bile salt synthesis in the rat.
Koopen NR; Post SM; Wolters H; Havinga R; Stellaard F; Boverhof R; Kuipers F; Princen HM
J Lipid Res; 1999 Jan; 40(1):100-8. PubMed ID: 9869655
[TBL] [Abstract][Full Text] [Related]
32. Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans.
Bertolotti M; Carulli L; Concari M; Martella P; Loria P; Tagliafico E; Ferrari S; Del Puppo M; Amati B; De Fabiani E; Crestani M; Amorotti C; Manenti A; Carubbi F; Pinetti A; Carulli N
Hepatology; 2001 Aug; 34(2):234-42. PubMed ID: 11481606
[TBL] [Abstract][Full Text] [Related]
33. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters.
Handelsman B; Bonorris G; Marks JW; Schoenfield LJ
Am J Physiol; 1982 Nov; 243(5):G424-7. PubMed ID: 7137357
[TBL] [Abstract][Full Text] [Related]
34. Bile acid synthesis and biliary hydrophobicity during obstructive jaundice in rats.
Naito T; Kuroki S; Chijiiwa K; Tanaka M
J Surg Res; 1996 Sep; 65(1):70-6. PubMed ID: 8895609
[TBL] [Abstract][Full Text] [Related]
35. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
[TBL] [Abstract][Full Text] [Related]
36. Permeability of the rat biliary tree to ursodeoxycholic acid.
Farges O; Corbic M; Dumont M; Maurice M; Erlinger S
Am J Physiol; 1989 Apr; 256(4 Pt 1):G653-60. PubMed ID: 2705526
[TBL] [Abstract][Full Text] [Related]
37. Role of hydrophilic bile acids and of sterols on cholelithiasis in the hamster.
Singhal AK; Cohen BI; Finver-Sadowsky J; McSherry CK; Mosbach EH
J Lipid Res; 1984 Jun; 25(6):564-70. PubMed ID: 6547738
[TBL] [Abstract][Full Text] [Related]
38. The role of dietary choline in the beneficial effects of lecithin on the secretion of biliary lipids in rats.
LeBlanc MJ; Gavino V; Pérea A; Yousef IM; Lévy E; Tuchweber B
Biochim Biophys Acta; 1998 Aug; 1393(2-3):223-34. PubMed ID: 9748591
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of ursodeoxycholic acid- and canrenoate-induced biliary bicarbonate secretion and the effect on glucose- and amino acid-induced cholestasis.
Omland E; Mathisen O
Scand J Gastroenterol; 1991 May; 26(5):513-22. PubMed ID: 1871544
[TBL] [Abstract][Full Text] [Related]
40. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
